Trial Profile
Study of pasireotide in patients with Cushing's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2016
Price :
$35
*
At a glance
- Drugs Pasireotide (Primary)
- Indications Cushing syndrome
- Focus Therapeutic Use
- 21 Jul 2016 New trial record